EP Patent

EP2357254A1 — Methods and reagents for treatment and diagnosis of age-related macular degeneration

Assigned to University of Iowa Research Foundation UIRF · Expires 2011-08-17 · 15y expired

What this patent protects

The invention relates to Factor H gene polymorphisms and haplotypes associated with an elevated or a reduced risk of AMD. The invention provides methods and reagents for diagnosis and treatment of AMD.

USPTO Abstract

The invention relates to Factor H gene polymorphisms and haplotypes associated with an elevated or a reduced risk of AMD. The invention provides methods and reagents for diagnosis and treatment of AMD.

Drugs covered by this patent

Patent Metadata

Patent number: EP2357254A1
Jurisdiction: EP
Classification: —
Expires: 2011-08-17
Drug substance claim: No
Drug product claim: No
Assignee: University of Iowa Research Foundation UIRF
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.